ACP
GILD icon

Aveo Capital Partners’s Gilead Sciences GILD Stock Holding History

Aveo Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,473
Closed -$443K – 369
2023
Q4 		$443K Buy
5,473
+435
+9% +$33.9K 0.05% 219
2023
Q3 		$378K Buy
5,038
+536
+12% +$41.2K 0.05% 232
2023
Q2 		$347K Buy
4,502
+230
+5% +$18.3K 0.04% 258
2023
Q1 		$354K Buy
4,272
+858
+25% +$71.1K 0.05% 244
2022
Q4 		$293K Buy
+3,414
New +$270K 0.04% 262

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aveo Capital Partners's GILD Position: Q1 2024 in Review

Aveo Capital Partners sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 5,473 shares — an estimated $443K sold.

Aveo Capital Partners first reported a position in GILD in Q4 2022 and held it in 5 quarters. The position peaked at $443K in Q4 2023. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Aveo Capital Partners reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Aveo Capital Partners sold 5,473 Gilead Sciences shares in Q1 2024, an estimated $443K.
  • Aveo Capital Partners first reported a position in Gilead Sciences in Q4 2022 and held it in 5 quarters.
  • Aveo Capital Partners's Gilead Sciences position peaked at $443K in Q4 2023.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Aveo Capital Partners's 13F filing for Q1 2024, filed 6 May 2024.